Global COVID-19 Medicine Market 2024 by Company, Regions, Type and Application, Forecast to 2030

December 2024 | 110 pages | ID: G80D245B6FBDEN
GlobalInfoResearch

Abstracts

According to our latest research, the global COVID-19 Medicine market size will reach USD million in 2030, growing at a CAGR of % over the analysis period.

The COVID-19 Medicine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Market segmentation

COVID-19 Medicine market is split by Type and by Application. For the period 2024-2030, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

• Tablet
• Injection

Market segment by Application, can be divided into

• Patients With Mild Symptoms
• Critically Ill
• Other

Market segment by players, this report covers

• Advanz Pharma
• Kyung Poong
• Mylan
• Novartis
• Sanofi
• Apotex
• Bayer
• Guangzhou Baiyunshan Guanghua Pharmaceutical
• Ipca Laboratories
• Sichuan Sunny Hope
• Zydus Cadila
• Teva
• Sun Pharma
• Rising Pharmaceutical
• KPC Group
• Bristol Laboratories
• Shanghai Zhongxisanwei
• Shanghai Pharma

Market segment by regions, regional analysis covers

• North America
• Europe
• Asia-Pacific (China, Japan, South Korea, Rest of Asia-Pacific)
• South America
• Middle East & Africa

The content of the study subjects, includes a total of 8 chapters:

Chapter 1, to describe COVID-19 Medicine product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of COVID-19 Medicine, with recent developments and future plans

Chapter 3, the COVID-19 Medicine competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4, to break the market size data at the region level, with key companies in the key region and COVID-19 Medicine market forecast, by regions, with revenue, from 2024 to 2030.

Chapter 5 and 6, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2024 to 2030.

Chapter 7 and 8, to describe COVID-19 Medicine research findings and conclusion, appendix and data source.

Contents

1 MARKET OVERVIEW

1.1 Product Overview and Scope of COVID-19 Medicine
1.2 Classification of COVID-19 Medicine by Type
  1.2.1 Overview: Global COVID-19 Medicine Market Size by Type: 2024 Versus 2030
  1.2.2 Global COVID-19 Medicine Revenue Market Share by Type in 2030
  1.2.3 Tablet
  1.2.4 Injection
1.3 Global COVID-19 Medicine Market by Application
  1.3.1 Overview: Global COVID-19 Medicine Market Size by Application: 2024 Versus 2030
  1.3.2 Patients With Mild Symptoms
  1.3.3 Critically Ill
  1.3.4 Other
1.4 Global COVID-19 Medicine Market Size & Forecast
1.5 Market Drivers, Restraints and Trends
  1.5.1 COVID-19 Medicine Market Drivers
  1.5.2 COVID-19 Medicine Market Restraints
  1.5.3 COVID-19 Medicine Trends Analysis

2 COMPANY PROFILES

2.1 Advanz Pharma
  2.1.1 Advanz Pharma Details
  2.1.2 Advanz Pharma Major Business
  2.1.3 Advanz Pharma COVID-19 Medicine Product and Solutions
  2.1.4 Advanz Pharma Recent Developments and Future Plans
2.2 Kyung Poong
  2.2.1 Kyung Poong Details
  2.2.2 Kyung Poong Major Business
  2.2.3 Kyung Poong COVID-19 Medicine Product and Solutions
  2.2.4 Kyung Poong Recent Developments and Future Plans
2.3 Mylan
  2.3.1 Mylan Details
  2.3.2 Mylan Major Business
  2.3.3 Mylan COVID-19 Medicine Product and Solutions
  2.3.4 Mylan Recent Developments and Future Plans
2.4 Novartis
  2.4.1 Novartis Details
  2.4.2 Novartis Major Business
  2.4.3 Novartis COVID-19 Medicine Product and Solutions
  2.4.4 Novartis Recent Developments and Future Plans
2.5 Sanofi
  2.5.1 Sanofi Details
  2.5.2 Sanofi Major Business
  2.5.3 Sanofi COVID-19 Medicine Product and Solutions
  2.5.4 Sanofi Recent Developments and Future Plans
2.6 Apotex
  2.6.1 Apotex Details
  2.6.2 Apotex Major Business
  2.6.3 Apotex COVID-19 Medicine Product and Solutions
  2.6.4 Apotex Recent Developments and Future Plans
2.7 Bayer
  2.7.1 Bayer Details
  2.7.2 Bayer Major Business
  2.7.3 Bayer COVID-19 Medicine Product and Solutions
  2.7.4 Bayer Recent Developments and Future Plans
2.8 Guangzhou Baiyunshan Guanghua Pharmaceutical
  2.8.1 Guangzhou Baiyunshan Guanghua Pharmaceutical Details
  2.8.2 Guangzhou Baiyunshan Guanghua Pharmaceutical Major Business
  2.8.3 Guangzhou Baiyunshan Guanghua Pharmaceutical COVID-19 Medicine Product and Solutions
  2.8.4 Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Developments and Future Plans
2.9 Ipca Laboratories
  2.9.1 Ipca Laboratories Details
  2.9.2 Ipca Laboratories Major Business
  2.9.3 Ipca Laboratories COVID-19 Medicine Product and Solutions
  2.9.4 Ipca Laboratories Recent Developments and Future Plans
2.10 Sichuan Sunny Hope
  2.10.1 Sichuan Sunny Hope Details
  2.10.2 Sichuan Sunny Hope Major Business
  2.10.3 Sichuan Sunny Hope COVID-19 Medicine Product and Solutions
  2.10.4 Sichuan Sunny Hope Recent Developments and Future Plans
2.11 Zydus Cadila
  2.11.1 Zydus Cadila Details
  2.11.2 Zydus Cadila Major Business
  2.11.3 Zydus Cadila COVID-19 Medicine Product and Solutions
  2.11.4 Zydus Cadila Recent Developments and Future Plans
2.12 Teva
  2.12.1 Teva Details
  2.12.2 Teva Major Business
  2.12.3 Teva COVID-19 Medicine Product and Solutions
  2.12.4 Teva Recent Developments and Future Plans
2.13 Sun Pharma
  2.13.1 Sun Pharma Details
  2.13.2 Sun Pharma Major Business
  2.13.3 Sun Pharma COVID-19 Medicine Product and Solutions
  2.13.4 Sun Pharma Recent Developments and Future Plans
2.14 Rising Pharmaceutical
  2.14.1 Rising Pharmaceutical Details
  2.14.2 Rising Pharmaceutical Major Business
  2.14.3 Rising Pharmaceutical COVID-19 Medicine Product and Solutions
  2.14.4 Rising Pharmaceutical Recent Developments and Future Plans
2.15 KPC Group
  2.15.1 KPC Group Details
  2.15.2 KPC Group Major Business
  2.15.3 KPC Group COVID-19 Medicine Product and Solutions
  2.15.4 KPC Group Recent Developments and Future Plans
2.16 Bristol Laboratories
  2.16.1 Bristol Laboratories Details
  2.16.2 Bristol Laboratories Major Business
  2.16.3 Bristol Laboratories COVID-19 Medicine Product and Solutions
  2.16.4 Bristol Laboratories Recent Developments and Future Plans
2.17 Shanghai Zhongxisanwei
  2.17.1 Shanghai Zhongxisanwei Details
  2.17.2 Shanghai Zhongxisanwei Major Business
  2.17.3 Shanghai Zhongxisanwei COVID-19 Medicine Product and Solutions
  2.17.4 Shanghai Zhongxisanwei Recent Developments and Future Plans
2.18 Shanghai Pharma
  2.18.1 Shanghai Pharma Details
  2.18.2 Shanghai Pharma Major Business
  2.18.3 Shanghai Pharma COVID-19 Medicine Product and Solutions
  2.18.4 Shanghai Pharma Recent Developments and Future Plans

3 MARKET COMPETITION, BY PLAYERS

3.1 Global COVID-19 Medicine Revenue and Share by Players (2024 & 2030)
3.2 COVID-19 Medicine Players Head Office, Products and Services Provided
3.3 COVID-19 Medicine Mergers & Acquisitions
3.4 COVID-19 Medicine New Entrants and Expansion Plans

4 GLOBAL COVID-19 MEDICINE FORECAST BY REGION

4.1 Global COVID-19 Medicine Market Size by Region: 2024 VS 2030
4.2 Global COVID-19 Medicine Market Size by Region, (2024-2030)
4.3 North America
  4.3.1 Key Companies of COVID-19 Medicine in North America
  4.3.2 Current Situation and Forecast of COVID-19 Medicine in North America
  4.3.3 North America COVID-19 Medicine Market Size and Prospect (2024-2030)
4.4 Europe
  4.4.1 Key Companies of COVID-19 Medicine in Europe
  4.4.2 Current Situation and Forecast of COVID-19 Medicine in Europe
  4.4.3 Europe COVID-19 Medicine Market Size and Prospect (2024-2030)
4.5 Asia-Pacific
  4.5.1 Key Companies of COVID-19 Medicine in Asia-Pacific
  4.5.2 Current Situation and Forecast of COVID-19 Medicine in Asia-Pacific
  4.5.3 Asia-Pacific COVID-19 Medicine Market Size and Prospect (2024-2030)
  4.5.4 China
  4.5.5 Japan
  4.5.6 South Korea
4.6 South America
  4.6.1 Key Companies of COVID-19 Medicine in South America
  4.6.2 Current Situation and Forecast of COVID-19 Medicine in South America
  4.6.3 South America COVID-19 Medicine Market Size and Prospect (2024-2030)
4.7 Middle East & Africa
  4.7.1 Key Companies of COVID-19 Medicine in Middle East & Africa
  4.7.2 Current Situation and Forecast of COVID-19 Medicine in Middle East & Africa
  4.7.3 Middle East & Africa COVID-19 Medicine Market Size and Prospect (2024-2030)

5 MARKET SIZE SEGMENT BY TYPE

5.1 Global COVID-19 Medicine Market Forecast by Type (2024-2030)
5.2 Global COVID-19 Medicine Market Share Forecast by Type (2024-2030)

6 MARKET SIZE SEGMENT BY APPLICATION

6.1 Global COVID-19 Medicine Market Forecast by Application (2024-2030)
6.2 Global COVID-19 Medicine Market Share Forecast by Application (2024-2030)

7 RESEARCH FINDINGS AND CONCLUSION

8 APPENDIX

8.1 Methodology
8.2 Research Process and Data Source
8.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Global COVID-19 Medicine Revenue by Type, (USD Million), 2024 VS 2030
Table 2. Global COVID-19 Medicine Revenue by Application, (USD Million), 2024 VS 2030
Table 3. Advanz Pharma Corporate Information, Head Office, and Major Competitors
Table 4. Advanz Pharma Major Business
Table 5. Advanz Pharma COVID-19 Medicine Product and Solutions
Table 6. Kyung Poong Corporate Information, Head Office, and Major Competitors
Table 7. Kyung Poong Major Business
Table 8. Kyung Poong COVID-19 Medicine Product and Solutions
Table 9. Mylan Corporate Information, Head Office, and Major Competitors
Table 10. Mylan Major Business
Table 11. Mylan COVID-19 Medicine Product and Solutions
Table 12. Novartis Corporate Information, Head Office, and Major Competitors
Table 13. Novartis Major Business
Table 14. Novartis COVID-19 Medicine Product and Solutions
Table 15. Sanofi Corporate Information, Head Office, and Major Competitors
Table 16. Sanofi Major Business
Table 17. Sanofi COVID-19 Medicine Product and Solutions
Table 18. Apotex Corporate Information, Head Office, and Major Competitors
Table 19. Apotex Major Business
Table 20. Apotex COVID-19 Medicine Product and Solutions
Table 21. Bayer Corporate Information, Head Office, and Major Competitors
Table 22. Bayer Major Business
Table 23. Bayer COVID-19 Medicine Product and Solutions
Table 24. Guangzhou Baiyunshan Guanghua Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 25. Guangzhou Baiyunshan Guanghua Pharmaceutical Major Business
Table 26. Guangzhou Baiyunshan Guanghua Pharmaceutical COVID-19 Medicine Product and Solutions
Table 27. Ipca Laboratories Corporate Information, Head Office, and Major Competitors
Table 28. Ipca Laboratories Major Business
Table 29. Ipca Laboratories COVID-19 Medicine Product and Solutions
Table 30. Sichuan Sunny Hope Corporate Information, Head Office, and Major Competitors
Table 31. Sichuan Sunny Hope Major Business
Table 32. Sichuan Sunny Hope COVID-19 Medicine Product and Solutions
Table 33. Zydus Cadila Corporate Information, Head Office, and Major Competitors
Table 34. Zydus Cadila Major Business
Table 35. Zydus Cadila COVID-19 Medicine Product and Solutions
Table 36. Teva Corporate Information, Head Office, and Major Competitors
Table 37. Teva Major Business
Table 38. Teva COVID-19 Medicine Product and Solutions
Table 39. Sun Pharma Corporate Information, Head Office, and Major Competitors
Table 40. Sun Pharma Major Business
Table 41. Sun Pharma COVID-19 Medicine Product and Solutions
Table 42. Rising Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 43. Rising Pharmaceutical Major Business
Table 44. Rising Pharmaceutical COVID-19 Medicine Product and Solutions
Table 45. KPC Group Corporate Information, Head Office, and Major Competitors
Table 46. KPC Group Major Business
Table 47. KPC Group COVID-19 Medicine Product and Solutions
Table 48. Bristol Laboratories Corporate Information, Head Office, and Major Competitors
Table 49. Bristol Laboratories Major Business
Table 50. Bristol Laboratories COVID-19 Medicine Product and Solutions
Table 51. Shanghai Zhongxisanwei Corporate Information, Head Office, and Major Competitors
Table 52. Shanghai Zhongxisanwei Major Business
Table 53. Shanghai Zhongxisanwei COVID-19 Medicine Product and Solutions
Table 54. Shanghai Pharma Corporate Information, Head Office, and Major Competitors
Table 55. Shanghai Pharma Major Business
Table 56. Shanghai Pharma COVID-19 Medicine Product and Solutions
Table 57. Global COVID-19 Medicine Revenue (USD Million) by Players (2024 & 2030)
Table 58. Global COVID-19 Medicine Revenue Share by Players (2024 & 2030)
Table 59. COVID-19 Medicine Players Head Office, Products and Services Provided
Table 60. COVID-19 Medicine Mergers & Acquisitions in the Past Five Years
Table 61. COVID-19 Medicine New Entrants and Expansion Plans
Table 62. Global Market COVID-19 Medicine Revenue (USD Million) Comparison by Region (2024 VS 2030)
Table 63. Global COVID-19 Medicine Revenue Market Share by Region (2024-2030)
Table 64. Key Companies of COVID-19 Medicine in North America
Table 65. Current Situation and Forecast of COVID-19 Medicine in North America
Table 66. Key Companies of COVID-19 Medicine in Europe
Table 67. Current Situation and Forecast of COVID-19 Medicine in Europe
Table 68. Key Companies of COVID-19 Medicine in Asia-Pacific
Table 69. Current Situation and Forecast of COVID-19 Medicine in Asia-Pacific
Table 70. Key Companies of COVID-19 Medicine in China
Table 71. Key Companies of COVID-19 Medicine in Japan
Table 72. Key Companies of COVID-19 Medicine in South Korea
Table 73. Key Companies of COVID-19 Medicine in South America
Table 74. Current Situation and Forecast of COVID-19 Medicine in South America
Table 75. Key Companies of COVID-19 Medicine in Middle East & Africa
Table 76. Current Situation and Forecast of COVID-19 Medicine in Middle East & Africa
Table 77. Global COVID-19 Medicine Revenue Forecast by Type (2024-2030)
Table 78. Global COVID-19 Medicine Revenue Forecast by Application (2024-2030)

List Of Figures

LIST OF FIGURES

Figure 1. COVID-19 Medicine Picture
Figure 2. Global COVID-19 Medicine Revenue Market Share by Type in 2030
Figure 3. Tablet
Figure 4. Injection
Figure 5. COVID-19 Medicine Revenue Market Share by Application in 2030
Figure 6. Patients With Mild Symptoms Picture
Figure 7. Critically Ill Picture
Figure 8. Other Picture
Figure 9. Global COVID-19 Medicine Market Size, (USD Million): 2024 VS 2030
Figure 10. Global COVID-19 Medicine Revenue and Forecast (2024-2030) & (USD Million)
Figure 11. COVID-19 Medicine Market Drivers
Figure 12. COVID-19 Medicine Market Restraints
Figure 13. COVID-19 Medicine Market Trends
Figure 14. Advanz Pharma Recent Developments and Future Plans
Figure 15. Kyung Poong Recent Developments and Future Plans
Figure 16. Mylan Recent Developments and Future Plans
Figure 17. Novartis Recent Developments and Future Plans
Figure 18. Sanofi Recent Developments and Future Plans
Figure 19. Apotex Recent Developments and Future Plans
Figure 20. Bayer Recent Developments and Future Plans
Figure 21. Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Developments and Future Plans
Figure 22. Ipca Laboratories Recent Developments and Future Plans
Figure 23. Sichuan Sunny Hope Recent Developments and Future Plans
Figure 24. Zydus Cadila Recent Developments and Future Plans
Figure 25. Teva Recent Developments and Future Plans
Figure 26. Sun Pharma Recent Developments and Future Plans
Figure 27. Rising Pharmaceutical Recent Developments and Future Plans
Figure 28. KPC Group Recent Developments and Future Plans
Figure 29. Bristol Laboratories Recent Developments and Future Plans
Figure 30. Shanghai Zhongxisanwei Recent Developments and Future Plans
Figure 31. Shanghai Pharma Recent Developments and Future Plans
Figure 32. Global COVID-19 Medicine Revenue Market Share by Region (2024-2030)
Figure 33. Global COVID-19 Medicine Revenue Market Share by Region in 2030
Figure 34. North America COVID-19 Medicine Revenue (USD Million) and Growth Rate (2024-2030)
Figure 35. Europe COVID-19 Medicine Revenue (USD Million) and Growth Rate (2024-2030)
Figure 36. Asia-Pacific COVID-19 Medicine Revenue (USD Million) and Growth Rate (2024-2030)
Figure 37. South America COVID-19 Medicine Revenue (USD Million) and Growth Rate (2024-2030)
Figure 38. Middle East & Africa COVID-19 Medicine Revenue (USD Million) and Growth Rate (2024-2030)
Figure 39. Global COVID-19 Medicine Market Share Forecast by Type (2024-2030)
Figure 40. Global COVID-19 Medicine Market Share Forecast by Application (2024-2030)
Figure 41. Methodology
Figure 42. Research Process and Data Source